Mirae Asset Global Investments Co., Ltd.

Position in MDGL — Madrigal Pharmaceuticals, Inc.

CIK 1569395 SEOUL, M5

Position in MDGL

as of Mar 31, 2026 · filed May 4, 2026 Compact

Position Value

$21,423,530

-$8,060,926 QoQ

Shares Held

40,926

-19.2% QoQ

Ownership

0.178%

of shares outstanding

% of Portfolio

0.07%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2023

12 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Mirae Asset Global Investments Co., Ltd. holds $260,099,014 across 207 Biotechnology names. MDGL ranks #3 (8.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	188,064	$83,978,097
2	REGN	Regeneron Pharmaceuticals, Inc.	84,608	$65,371,524
3	MDGL	Madrigal Pharmaceuticals, Inc. This page	40,926	$21,423,530
4	ALNY	Alnylam Pharmaceuticals, Inc.	56,391	$18,658,089
5	INSM	INSMED Inc	92,080	$15,056,920
6	ONC	BeOne Medicines Ltd.	23,740	$7,050,067
7	RPRX	Royalty Pharma plc	146,024	$7,004,771
8	INCY	Incyte Corp	47,258	$4,447,922

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$21,423,530	40,926	-19.2%	Shares	Defined	2026-05-04
2025-12-31	$29,484,456	50,631	+0.1%	Shares	Sole	2026-01-26
2025-09-30	$23,198,104	50,578	-28.3%	Shares	Sole	2025-11-03
2025-06-30	$21,353,975	70,559	+0.3%	Shares	Sole	2025-07-21
2025-03-31	$23,299,049	70,341	+0.2%	Shares	Defined	2025-04-24
2024-12-31	$21,655,133	70,179	-8.6%	Shares	Defined	2025-01-27
2024-09-30	$16,303,164	76,822	-7.1%	Shares	Sole	2024-10-23
2024-06-30	$23,179,597	82,737	-10.3%	Shares	Sole	2024-07-30
2024-03-31	$24,635,239	92,253	+50.0%	Shares	Defined	2024-05-01
2023-12-31	$14,231,719	61,508	-1.2%	Shares	Defined	2024-01-24
2023-09-30	$9,094,639	62,275	+32.6%	Shares	Sole	2023-10-26
2023-06-30	$10,850,301	46,971	—	Shares	Sole	2023-08-10
No filing history on record for this holder in this stock.